Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06293963 · ClinicalTrials.gov registry record · NA
Front-of-package Label Effects in Latine and Limited English Proficiency Populations
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 3,306
- Enrollment target
NCT06293963: Completed NA study, sponsored by University of North Carolina, Chapel Hill.
NCT06293963 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 3,306 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (135% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06293963, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,306 participants
- Enrollment target
Study Summary
The goal of this experiment is to examine the effects of 4 types of front-of-package food labels among a sample of Latino adults. The main questions this experiment aims to answer are: What front-of-package label design is most effective in helping Latino and low English proficiency consumers identify healthier and less healthy food products? What front-of-package label design is most effective in helping Latino and low English proficiency consumers choose healthier food products? Additionally, this experiment also aims to answer the following question: Do the benefits of front-of-package label designs differ by English proficiency and parental status? Participants will be randomly assigned to 1 of 4 types of front-of-package label designs and view their assigned label design on 3 sets of products. Each set will display 3 similar products, each high in either 1, 2, or 3 nutrients of concern. For each set, participants will select the product that they believe to be the healthiest, least healthy, and the product that they would most want to consume. Researchers will compare results across label designs.
Primary Outcome
Correct identification of healthiest product will be measured by survey. Responses will be coded in a dichotomous 0-1 range, where 1 indicates that the participant correctly identified the healthiest product and 0 indicates that the participant incorrectly identified one of the other two less healthy products as the healthiest product.
Interventions
- BEHAVIORAL Guideline Daily Amounts label
- BEHAVIORAL Interpretive text-only label
- BEHAVIORAL Interpretive magnifying glass icon label
- BEHAVIORAL Separated interpretive magnifying glass icon label
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,306 participants |
| Start Date | 2024-08-09 |
| Est. Completion | 2024-09-11 |
| Phase | NA |
What the finished NCT06293963 record still lists
NCT06293963 is an interventional study that assigns participants to a tested intervention. Its 3,306 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (135% higher).
The record links to 0 conditions, and to 4 interventions - of which Guideline Daily Amounts label is the first listed.
NCT06293963 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06293963 about?
NCT06293963 is a clinical study titled "Front-of-package Label Effects in Latine and Limited English Proficiency Populations". The goal of this experiment is to examine the effects of 4 types of front-of-package food labels among a sample of Latino adults. The main questions this experiment aims to answer are: What front-of-package label design is most effective in helping Latino and low English proficiency consumers ident...
What is the current status of trial NCT06293963?
This trial is currently completed. It is a NA study. The enrollment target is 3,306 participants. The study started on 2024-08-09. Estimated completion is 2024-09-11.
What interventions are being tested in trial NCT06293963?
The interventions under investigation include: Guideline Daily Amounts label (BEHAVIORAL), Interpretive text-only label (BEHAVIORAL), Interpretive magnifying glass icon label (BEHAVIORAL), Separated interpretive magnifying glass icon label (BEHAVIORAL).
Who is sponsoring clinical trial NCT06293963?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06293963's enrollment target sits among peer trials
3,306 37th of 2000 higher than 1,964 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03674307 · 3,306 participants · NA
Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates
- NCT07214610 · 3,300 participants · NA
Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study
- NCT06815536 · 3,291 participants
Master Protocol for Evaluating Multiple Infection Diagnostics for Ciprofloxacin-Resistant Neisseria Gonorrhoeae
- NCT06543446 · 3,290 participants · NA
Comparative Effectiveness of Prophylactic ICD Versus Non-ICD Therapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI